{
    "info": {
        "nct_id": "NCT06726161",
        "official_title": "Phase 1/1b Single Arm, Open-label Trial of Theranostic Pair RYZ811 (diagnostic) and RYZ801 (therapeutic) to Identify and Treat Subjects with GPC3+ Unresectable Hepatocellular Carcinoma (HCC)",
        "inclusion_criteria": "* Age of at least 18 years at the time of signing the informed consent form (ICF)\n* Histologically/cytologically confirmed diagnosis of HCC.\n* Barcelona Clinic Liver Cancer (BCLC) Stage C or BCLC Stage B not amenable to locoregional therapy\n* Child-Pugh A\n* ECOG PS 0-1\n* At least 1 prior systemic therapy for unresectable HCC\n* Measurable disease per RECIST v1.1\n* Sufficient renal function\n* Adequate hematologic function\n* Adequate hepatic function\n* The subject must have recovered from toxicities related to prior treatments to ≤Grade 1, unless clinically nonsignificant and/or stable on supportive therapy\n* If HBV or HCV infection: Disease managed per local practice; antiviral treatment is allowed.\n* Gastric or esophageal varices previously treated with endoscopic therapy according to institutional standards are permitted if no clinically significant bleeding\n* For women of childbearing potential (WOCBP):\n\n  * Negative serum pregnancy test within 48 hours prior to the first dose of RYZ811\n  * Agreement to use barrier contraception and a second form of highly effective contraception\n* For sexually active males:\n\n  * Must use a condom during intercourse\n  * Male subjects whose sexual partners are WOCBP must also agree to use a second form of highly effective contraception\n  * A condom is required to be used also by vasectomized men\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Subjects with fibrolamellar carcinoma, sarcomatoid HCC or combined hepatocellular cholangiocarcinoma\n* Prior liver transplantation or candidates for liver transplantation\n* Known hypersensitivity to 68Ga, 225Ac or any of the excipients of RYZ811 or RYZ801\n* Portal vein tumor thrombosis classified as Vp4\n* Documented hepatic encephalopathy\n* Clinically meaningful ascites\n* Prior EBRT to the liver\n* Prior EBRT to >25% of the bone marrow\n* Prior liver radioembolization\n* Previously treated central nervous system (CNS) metastasis without recovery from acute side effects\n* Documented history of idiopathic pulmonary fibrosis (IPF), interstitial lung disease (ILD) or pneumonitis\n* Uncontrolled significant intercurrent illness including, but not limited to:\n\n  * QT interval corrected for heart rate using Fridericia's formula (QTcF) >470 ms\n  * Hemoglobin A1c (HgB A1c) ≥8%\n  * Uncontrolled hypertension\n  * Significant cardiovascular disease or heart failure\n* History of clinically significant bleeding\n* Prior participation in any interventional clinical study\n* Current somatic or psychiatric disease/condition that may interfere with the objectives and assessments of the study\n* Have a history of primary malignancy within the past 3 years other than (1) HCC, (2) adequately treated carcinoma in situ or non-melanoma carcinoma of the skin, (3) any other curatively treated malignancy that is not expected to require treatment for recurrence during participation in the study, or (4) an untreated cancer on active surveillance that may not affect the subject's survival status for >3 years\n* Subject requires other treatment that in the opinion of the Investigator would be more appropriate than what is offered in the study\n* Pregnancy or breastfeeding",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* For sexually active males:",
            "criterions": [
                {
                    "exact_snippets": "For sexually active males",
                    "criterion": "sexually active male",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "male"
                        },
                        {
                            "requirement_type": "sexual activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Sufficient renal function",
            "criterions": [
                {
                    "exact_snippets": "Sufficient renal function",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "sufficiency",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* At least 1 prior systemic therapy for unresectable HCC",
            "criterions": [
                {
                    "exact_snippets": "At least 1 prior systemic therapy for unresectable HCC",
                    "criterion": "prior systemic therapy for unresectable HCC",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must use a condom during intercourse",
            "criterions": [
                {
                    "exact_snippets": "Must use a condom during intercourse",
                    "criterion": "condom use during intercourse",
                    "requirements": [
                        {
                            "requirement_type": "usage",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For women of childbearing potential (WOCBP):",
            "criterions": [
                {
                    "exact_snippets": "For women of childbearing potential (WOCBP)",
                    "criterion": "sex and reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "childbearing potential",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG PS 0-1",
            "criterions": [
                {
                    "exact_snippets": "ECOG PS 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Measurable disease per RECIST v1.1",
            "criterions": [
                {
                    "exact_snippets": "Measurable disease per RECIST v1.1",
                    "criterion": "disease",
                    "requirements": [
                        {
                            "requirement_type": "measurability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_criteria",
                            "expected_value": "RECIST v1.1"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Child-Pugh A",
            "criterions": [
                {
                    "exact_snippets": "Child-Pugh A",
                    "criterion": "Child-Pugh score",
                    "requirements": [
                        {
                            "requirement_type": "score category",
                            "expected_value": "A"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically/cytologically confirmed diagnosis of HCC.",
            "criterions": [
                {
                    "exact_snippets": "Histologically/cytologically confirmed diagnosis of HCC",
                    "criterion": "diagnosis of HCC",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The subject must have recovered from toxicities related to prior treatments to ≤Grade 1, unless clinically nonsignificant and/or stable on supportive therapy",
            "criterions": [
                {
                    "exact_snippets": "The subject must have recovered from toxicities related to prior treatments to ≤Grade 1",
                    "criterion": "toxicities related to prior treatments",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "Grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unless clinically nonsignificant and/or stable on supportive therapy",
                    "criterion": "toxicities related to prior treatments",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": "nonsignificant"
                        },
                        {
                            "requirement_type": "stability on supportive therapy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age of at least 18 years at the time of signing the informed consent form (ICF)",
            "criterions": [
                {
                    "exact_snippets": "Age of at least 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Gastric or esophageal varices previously treated with endoscopic therapy according to institutional standards are permitted if no clinically significant bleeding",
            "criterions": [
                {
                    "exact_snippets": "Gastric or esophageal varices previously treated with endoscopic therapy according to institutional standards",
                    "criterion": "gastric or esophageal varices",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": "previously treated with endoscopic therapy according to institutional standards"
                        }
                    ]
                },
                {
                    "exact_snippets": "if no clinically significant bleeding",
                    "criterion": "clinically significant bleeding",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A condom is required to be used also by vasectomized men",
            "criterions": [
                {
                    "exact_snippets": "A condom is required to be used also by vasectomized men",
                    "criterion": "condom use",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "applicability",
                            "expected_value": "vasectomized men"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate hematologic function",
            "criterions": [
                {
                    "exact_snippets": "Adequate hematologic function",
                    "criterion": "hematologic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate hepatic function",
            "criterions": [
                {
                    "exact_snippets": "Adequate hepatic function",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Negative serum pregnancy test within 48 hours prior to the first dose of RYZ811",
            "criterions": [
                {
                    "exact_snippets": "Negative serum pregnancy test within 48 hours prior to the first dose of RYZ811",
                    "criterion": "serum pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "within 48 hours prior to the first dose of RYZ811"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* If HBV or HCV infection: Disease managed per local practice; antiviral treatment is allowed.",
            "criterions": [
                {
                    "exact_snippets": "If HBV or HCV infection",
                    "criterion": "HBV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "If HBV or HCV infection",
                    "criterion": "HCV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Disease managed per local practice",
                    "criterion": "management of HBV or HCV infection",
                    "requirements": [
                        {
                            "requirement_type": "management",
                            "expected_value": "per local practice"
                        }
                    ]
                },
                {
                    "exact_snippets": "antiviral treatment is allowed",
                    "criterion": "antiviral treatment for HBV or HCV infection",
                    "requirements": [
                        {
                            "requirement_type": "allowance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Male subjects whose sexual partners are WOCBP must also agree to use a second form of highly effective contraception",
            "criterions": [
                {
                    "exact_snippets": "Male subjects whose sexual partners are WOCBP",
                    "criterion": "subject sex and partner reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "male"
                        },
                        {
                            "requirement_type": "sexual partner reproductive status",
                            "expected_value": "woman of childbearing potential"
                        }
                    ]
                },
                {
                    "exact_snippets": "must also agree to use a second form of highly effective contraception",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "number of forms",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "forms"
                            }
                        },
                        {
                            "requirement_type": "effectiveness",
                            "expected_value": "highly effective"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Barcelona Clinic Liver Cancer (BCLC) Stage C or BCLC Stage B not amenable to locoregional therapy",
            "criterions": [
                {
                    "exact_snippets": "Barcelona Clinic Liver Cancer (BCLC) Stage C",
                    "criterion": "BCLC stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "C"
                        }
                    ]
                },
                {
                    "exact_snippets": "BCLC Stage B not amenable to locoregional therapy",
                    "criterion": "BCLC stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "B"
                        },
                        {
                            "requirement_type": "amenability to locoregional therapy",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Portal vein tumor thrombosis classified as Vp4",
            "criterions": [
                {
                    "exact_snippets": "Portal vein tumor thrombosis classified as Vp4",
                    "criterion": "portal vein tumor thrombosis",
                    "requirements": [
                        {
                            "requirement_type": "classification",
                            "expected_value": "Vp4"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Documented hepatic encephalopathy",
            "criterions": [
                {
                    "exact_snippets": "Documented hepatic encephalopathy",
                    "criterion": "hepatic encephalopathy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior liver radioembolization",
            "criterions": [
                {
                    "exact_snippets": "Prior liver radioembolization",
                    "criterion": "liver radioembolization",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior EBRT to the liver",
            "criterions": [
                {
                    "exact_snippets": "Prior EBRT to the liver",
                    "criterion": "external beam radiation therapy (EBRT) to the liver",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled hypertension",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled hypertension",
                    "criterion": "hypertension",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled significant intercurrent illness including, but not limited to:",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled significant intercurrent illness",
                    "criterion": "intercurrent illness",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin A1c (HgB A1c) ≥8%",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin A1c (HgB A1c) ≥8%",
                    "criterion": "Hemoglobin A1c (HgB A1c)",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 8,
                                "unit": "%"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior liver transplantation or candidates for liver transplantation",
            "criterions": [
                {
                    "exact_snippets": "Prior liver transplantation",
                    "criterion": "liver transplantation",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "candidates for liver transplantation",
                    "criterion": "liver transplantation candidacy",
                    "requirements": [
                        {
                            "requirement_type": "candidacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects with fibrolamellar carcinoma, sarcomatoid HCC or combined hepatocellular cholangiocarcinoma",
            "criterions": [
                {
                    "exact_snippets": "fibrolamellar carcinoma",
                    "criterion": "fibrolamellar carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sarcomatoid HCC",
                    "criterion": "sarcomatoid HCC",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "combined hepatocellular cholangiocarcinoma",
                    "criterion": "combined hepatocellular cholangiocarcinoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinically meaningful ascites",
            "criterions": [
                {
                    "exact_snippets": "Clinically meaningful ascites",
                    "criterion": "ascites",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior EBRT to >25% of the bone marrow",
            "criterions": [
                {
                    "exact_snippets": "Prior EBRT to >25% of the bone marrow",
                    "criterion": "prior EBRT to bone marrow",
                    "requirements": [
                        {
                            "requirement_type": "extent",
                            "expected_value": {
                                "operator": ">",
                                "value": 25,
                                "unit": "% of the bone marrow"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior participation in any interventional clinical study",
            "criterions": [
                {
                    "exact_snippets": "Prior participation in any interventional clinical study",
                    "criterion": "prior participation in interventional clinical study",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Documented history of idiopathic pulmonary fibrosis (IPF), interstitial lung disease (ILD) or pneumonitis",
            "criterions": [
                {
                    "exact_snippets": "Documented history of idiopathic pulmonary fibrosis (IPF)",
                    "criterion": "idiopathic pulmonary fibrosis (IPF)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Documented history of ... interstitial lung disease (ILD)",
                    "criterion": "interstitial lung disease (ILD)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Documented history of ... pneumonitis",
                    "criterion": "pneumonitis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Previously treated central nervous system (CNS) metastasis without recovery from acute side effects",
            "criterions": [
                {
                    "exact_snippets": "Previously treated central nervous system (CNS) metastasis",
                    "criterion": "central nervous system (CNS) metastasis",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": "previously treated"
                        }
                    ]
                },
                {
                    "exact_snippets": "without recovery from acute side effects",
                    "criterion": "recovery from acute side effects",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Significant cardiovascular disease or heart failure",
            "criterions": [
                {
                    "exact_snippets": "Significant cardiovascular disease",
                    "criterion": "cardiovascular disease",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    ]
                },
                {
                    "exact_snippets": "heart failure",
                    "criterion": "heart failure",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* QT interval corrected for heart rate using Fridericia's formula (QTcF) >470 ms",
            "criterions": [
                {
                    "exact_snippets": "QT interval corrected for heart rate using Fridericia's formula (QTcF) >470 ms",
                    "criterion": "QTcF (QT interval corrected for heart rate using Fridericia's formula)",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 470,
                                "unit": "ms"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known hypersensitivity to 68Ga, 225Ac or any of the excipients of RYZ811 or RYZ801",
            "criterions": [
                {
                    "exact_snippets": "Known hypersensitivity to 68Ga",
                    "criterion": "hypersensitivity to 68Ga",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known hypersensitivity to ... 225Ac",
                    "criterion": "hypersensitivity to 225Ac",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Known hypersensitivity to ... any of the excipients of RYZ811 or RYZ801",
                    "criterion": "hypersensitivity to excipients of RYZ811 or RYZ801",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current somatic or psychiatric disease/condition that may interfere with the objectives and assessments of the study",
            "criterions": [
                {
                    "exact_snippets": "Current somatic or psychiatric disease/condition",
                    "criterion": "somatic disease or condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Current somatic or psychiatric disease/condition",
                    "criterion": "psychiatric disease or condition",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "may interfere with the objectives and assessments of the study",
                    "criterion": "potential to interfere with study objectives and assessments",
                    "requirements": [
                        {
                            "requirement_type": "potential interference",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of clinically significant bleeding",
            "criterions": [
                {
                    "exact_snippets": "History of clinically significant bleeding",
                    "criterion": "clinically significant bleeding",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject requires other treatment that in the opinion of the Investigator would be more appropriate than what is offered in the study",
            "criterions": [
                {
                    "exact_snippets": "Subject requires other treatment that in the opinion of the Investigator would be more appropriate than what is offered in the study",
                    "criterion": "requirement for other treatment",
                    "requirements": [
                        {
                            "requirement_type": "necessity (per investigator judgment)",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnancy or breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "Pregnancy",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "breastfeeding",
                    "criterion": "breastfeeding",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have a history of primary malignancy within the past 3 years other than (1) HCC, (2) adequately treated carcinoma in situ or non-melanoma carcinoma of the skin, (3) any other curatively treated malignancy that is not expected to require treatment for recurrence during participation in the study, or (4) an untreated cancer on active surveillance that may not affect the subject's survival status for >3 years",
            "criterions": [
                {
                    "exact_snippets": "history of primary malignancy within the past 3 years",
                    "criterion": "history of primary malignancy",
                    "requirements": [
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "HCC",
                    "criterion": "HCC (hepatocellular carcinoma)",
                    "requirements": [
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "adequately treated carcinoma in situ or non-melanoma carcinoma of the skin",
                    "criterion": "carcinoma in situ or non-melanoma carcinoma of the skin",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "adequately treated"
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any other curatively treated malignancy that is not expected to require treatment for recurrence during participation in the study",
                    "criterion": "other curatively treated malignancy",
                    "requirements": [
                        {
                            "requirement_type": "treatment status",
                            "expected_value": "curatively treated"
                        },
                        {
                            "requirement_type": "expected need for recurrence treatment during study",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "an untreated cancer on active surveillance that may not affect the subject's survival status for >3 years",
                    "criterion": "untreated cancer on active surveillance",
                    "requirements": [
                        {
                            "requirement_type": "effect on survival status for >3 years",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "* Agreement to use barrier contraception and a second form of highly effective contraception",
            "criterions": [
                {
                    "exact_snippets": "Agreement to use barrier contraception",
                    "criterion": "barrier contraception",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "agreement to use ... a second form of highly effective contraception",
                    "criterion": "second form of highly effective contraception",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}